Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update - Jaworski, Carolin; Iliev, Petar; Wängler, Carmen; Wängler, Björn; Page, Brent; Schirrmacher, Ralf; Bailey, Justin (Expert opinion on therapeutic patents, 2023)